P a g e | 7
11. At GM and Takata, whose improper actions finally came to light, a whistleblower raised objections
to the actions before or very early in the production process. Why were their concerns ignored and
risks taken? In VW’s case, why didn’t a whistleblower come forward? What aspects of governance
were lacking in each company?
At GM and Takata the whistleblower’s concerns were not taken very seriously. Neither company
had a whistleblowing program that brought complaints to the senior officers and directors of
the company. The culture in both companies was also not encouraging to whistleblowers. In
GM, the dominant pressure was to keep costs low, so changes that would increase costs were
ignored. The potential harm, cost and reputational loss involved was simply not taken into
12. The CEOs of Valeant Pharmaceuticals and Turing Pharmaceuticals took the view that they could jack
up the price of their drugs by huge percentages because they could, and they failed to consider
seriously enough whether they should. Whose fault was this? In a well-functioning corporate
governance system, what measures should be in place to control such actions?
The CEOs of Valeant and Turing had, for some time, gotten away with the strategy of buying
fully developed drugs for which alternatives didn’t exist and jacking up their prices to sky-high
levels, and this would have continued except for the public outcry and political scrutiny that